King Confident Of Embeda Opioid Approval In 2009; REMS Is The Final Hurdle

King Pharmaceuticals believes the FDA review of its abuse-resistant painkiller Embeda is "substantially complete," and that the company will be able to launch the drug in 2009, CEO Brian Markison assured investors during an earnings call Feb. 26